The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Sumatriptan Succinate-Global Market Insights and Sales Trends 2025
Synopsis
Sumatriptan is used to treat acute migraine headaches in adults. It is not used to prevent migraine headaches and is not used for cluster headaches. Sumatriptan works in the brain to relieve the pain from migraine headaches. It belongs to the group of medicines called triptans.
The global Sumatriptan Succinate market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Sumatriptan Succinate in various end use industries. The expanding demands from the Hospital Pharmacies and Drug Stores, are propelling Sumatriptan Succinate market. Tablet, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Subcutaneous Injection segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Sumatriptan Succinate market, driven by demand from China, the second largest economy with some signs of stabilising, the Sumatriptan Succinate market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Sumatriptan Succinate, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Sumatriptan Succinate market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Sumatriptan Succinate market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Sumatriptan Succinate sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Sumatriptan Succinate covered in this report include GlaxoSmithKline, Pfizer, Teva, Endo Pharmaceuticals, Mylan, Merck and Sun Pharmaceutical, etc.
The global Sumatriptan Succinate market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
GlaxoSmithKline
Pfizer
Teva
Endo Pharmaceuticals
Mylan
Merck
Sun Pharmaceutical
Global Sumatriptan Succinate market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Sumatriptan Succinate market, Segment by Type:
Tablet
Subcutaneous Injection
Nasal Spray
Global Sumatriptan Succinate market, by Application
Hospital Pharmacies
Drug Stores
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Sumatriptan Succinate manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Sumatriptan Succinate in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Sumatriptan is used to treat acute migraine headaches in adults. It is not used to prevent migraine headaches and is not used for cluster headaches. Sumatriptan works in the brain to relieve the pain from migraine headaches. It belongs to the group of medicines called triptans.
The global Sumatriptan Succinate market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Sumatriptan Succinate in various end use industries. The expanding demands from the Hospital Pharmacies and Drug Stores, are propelling Sumatriptan Succinate market. Tablet, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Subcutaneous Injection segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Sumatriptan Succinate market, driven by demand from China, the second largest economy with some signs of stabilising, the Sumatriptan Succinate market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Sumatriptan Succinate, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Sumatriptan Succinate market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Sumatriptan Succinate market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Sumatriptan Succinate sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Sumatriptan Succinate covered in this report include GlaxoSmithKline, Pfizer, Teva, Endo Pharmaceuticals, Mylan, Merck and Sun Pharmaceutical, etc.
The global Sumatriptan Succinate market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
GlaxoSmithKline
Pfizer
Teva
Endo Pharmaceuticals
Mylan
Merck
Sun Pharmaceutical
Global Sumatriptan Succinate market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Sumatriptan Succinate market, Segment by Type:
Tablet
Subcutaneous Injection
Nasal Spray
Global Sumatriptan Succinate market, by Application
Hospital Pharmacies
Drug Stores
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Sumatriptan Succinate manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Sumatriptan Succinate in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Sumatriptan Succinate Market Overview
1.1 Sumatriptan Succinate Product Overview
1.2 Sumatriptan Succinate Market Segment by Type
1.2.1 Tablet
1.2.2 Subcutaneous Injection
1.2.3 Nasal Spray
1.3 Global Sumatriptan Succinate Market Size by Type
1.3.1 Global Sumatriptan Succinate Market Size Overview by Type (2018-2029)
1.3.2 Global Sumatriptan Succinate Historic Market Size Review by Type (2018-2023)
1.3.3 Global Sumatriptan Succinate Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Sumatriptan Succinate Sales Breakdown by Type (2018-2023)
1.4.2 Europe Sumatriptan Succinate Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Sumatriptan Succinate Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Sumatriptan Succinate Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Sumatriptan Succinate Sales Breakdown by Type (2018-2023)
2 Global Sumatriptan Succinate Market Competition by Company
2.1 Global Top Players by Sumatriptan Succinate Sales (2018-2023)
2.2 Global Top Players by Sumatriptan Succinate Revenue (2018-2023)
2.3 Global Top Players by Sumatriptan Succinate Price (2018-2023)
2.4 Global Top Manufacturers Sumatriptan Succinate Manufacturing Base Distribution, Sales Area, Product Type
2.5 Sumatriptan Succinate Market Competitive Situation and Trends
2.5.1 Sumatriptan Succinate Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Sumatriptan Succinate Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Sumatriptan Succinate as of 2022)
2.7 Date of Key Manufacturers Enter into Sumatriptan Succinate Market
2.8 Key Manufacturers Sumatriptan Succinate Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Sumatriptan Succinate Status and Outlook by Region
3.1 Global Sumatriptan Succinate Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Sumatriptan Succinate Historic Market Size by Region
3.2.1 Global Sumatriptan Succinate Sales in Volume by Region (2018-2023)
3.2.2 Global Sumatriptan Succinate Sales in Value by Region (2018-2023)
3.2.3 Global Sumatriptan Succinate Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Sumatriptan Succinate Forecasted Market Size by Region
3.3.1 Global Sumatriptan Succinate Sales in Volume by Region (2024-2029)
3.3.2 Global Sumatriptan Succinate Sales in Value by Region (2024-2029)
3.3.3 Global Sumatriptan Succinate Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Sumatriptan Succinate by Application
4.1 Sumatriptan Succinate Market Segment by Application
4.1.1 Hospital Pharmacies
4.1.2 Drug Stores
4.2 Global Sumatriptan Succinate Market Size by Application
4.2.1 Global Sumatriptan Succinate Market Size Overview by Application (2018-2029)
4.2.2 Global Sumatriptan Succinate Historic Market Size Review by Application (2018-2023)
4.2.3 Global Sumatriptan Succinate Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Sumatriptan Succinate Sales Breakdown by Application (2018-2023)
4.3.2 Europe Sumatriptan Succinate Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Sumatriptan Succinate Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Sumatriptan Succinate Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Sumatriptan Succinate Sales Breakdown by Application (2018-2023)
5 North America Sumatriptan Succinate by Country
5.1 North America Sumatriptan Succinate Historic Market Size by Country
5.1.1 North America Sumatriptan Succinate Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Sumatriptan Succinate Sales in Volume by Country (2018-2023)
5.1.3 North America Sumatriptan Succinate Sales in Value by Country (2018-2023)
5.2 North America Sumatriptan Succinate Forecasted Market Size by Country
5.2.1 North America Sumatriptan Succinate Sales in Volume by Country (2024-2029)
5.2.2 North America Sumatriptan Succinate Sales in Value by Country (2024-2029)
6 Europe Sumatriptan Succinate by Country
6.1 Europe Sumatriptan Succinate Historic Market Size by Country
6.1.1 Europe Sumatriptan Succinate Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Sumatriptan Succinate Sales in Volume by Country (2018-2023)
6.1.3 Europe Sumatriptan Succinate Sales in Value by Country (2018-2023)
6.2 Europe Sumatriptan Succinate Forecasted Market Size by Country
6.2.1 Europe Sumatriptan Succinate Sales in Volume by Country (2024-2029)
6.2.2 Europe Sumatriptan Succinate Sales in Value by Country (2024-2029)
7 Asia-Pacific Sumatriptan Succinate by Region
7.1 Asia-Pacific Sumatriptan Succinate Historic Market Size by Region
7.1.1 Asia-Pacific Sumatriptan Succinate Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Sumatriptan Succinate Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Sumatriptan Succinate Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Sumatriptan Succinate Forecasted Market Size by Region
7.2.1 Asia-Pacific Sumatriptan Succinate Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Sumatriptan Succinate Sales in Value by Region (2024-2029)
8 Latin America Sumatriptan Succinate by Country
8.1 Latin America Sumatriptan Succinate Historic Market Size by Country
8.1.1 Latin America Sumatriptan Succinate Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Sumatriptan Succinate Sales in Volume by Country (2018-2023)
8.1.3 Latin America Sumatriptan Succinate Sales in Value by Country (2018-2023)
8.2 Latin America Sumatriptan Succinate Forecasted Market Size by Country
8.2.1 Latin America Sumatriptan Succinate Sales in Volume by Country (2024-2029)
8.2.2 Latin America Sumatriptan Succinate Sales in Value by Country (2024-2029)
9 Middle East and Africa Sumatriptan Succinate by Country
9.1 Middle East and Africa Sumatriptan Succinate Historic Market Size by Country
9.1.1 Middle East and Africa Sumatriptan Succinate Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Sumatriptan Succinate Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Sumatriptan Succinate Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Sumatriptan Succinate Forecasted Market Size by Country
9.2.1 Middle East and Africa Sumatriptan Succinate Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Sumatriptan Succinate Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 GlaxoSmithKline
10.1.1 GlaxoSmithKline Company Information
10.1.2 GlaxoSmithKline Introduction and Business Overview
10.1.3 GlaxoSmithKline Sumatriptan Succinate Sales, Revenue and Gross Margin (2018-2023)
10.1.4 GlaxoSmithKline Sumatriptan Succinate Products Offered
10.1.5 GlaxoSmithKline Recent Development
10.2 Pfizer
10.2.1 Pfizer Company Information
10.2.2 Pfizer Introduction and Business Overview
10.2.3 Pfizer Sumatriptan Succinate Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Pfizer Sumatriptan Succinate Products Offered
10.2.5 Pfizer Recent Development
10.3 Teva
10.3.1 Teva Company Information
10.3.2 Teva Introduction and Business Overview
10.3.3 Teva Sumatriptan Succinate Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Teva Sumatriptan Succinate Products Offered
10.3.5 Teva Recent Development
10.4 Endo Pharmaceuticals
10.4.1 Endo Pharmaceuticals Company Information
10.4.2 Endo Pharmaceuticals Introduction and Business Overview
10.4.3 Endo Pharmaceuticals Sumatriptan Succinate Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Endo Pharmaceuticals Sumatriptan Succinate Products Offered
10.4.5 Endo Pharmaceuticals Recent Development
10.5 Mylan
10.5.1 Mylan Company Information
10.5.2 Mylan Introduction and Business Overview
10.5.3 Mylan Sumatriptan Succinate Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Mylan Sumatriptan Succinate Products Offered
10.5.5 Mylan Recent Development
10.6 Merck
10.6.1 Merck Company Information
10.6.2 Merck Introduction and Business Overview
10.6.3 Merck Sumatriptan Succinate Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Merck Sumatriptan Succinate Products Offered
10.6.5 Merck Recent Development
10.7 Sun Pharmaceutical
10.7.1 Sun Pharmaceutical Company Information
10.7.2 Sun Pharmaceutical Introduction and Business Overview
10.7.3 Sun Pharmaceutical Sumatriptan Succinate Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Sun Pharmaceutical Sumatriptan Succinate Products Offered
10.7.5 Sun Pharmaceutical Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Sumatriptan Succinate Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Sumatriptan Succinate Industrial Chain Analysis
11.4 Sumatriptan Succinate Market Dynamics
11.4.1 Sumatriptan Succinate Industry Trends
11.4.2 Sumatriptan Succinate Market Drivers
11.4.3 Sumatriptan Succinate Market Challenges
11.4.4 Sumatriptan Succinate Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Sumatriptan Succinate Distributors
12.3 Sumatriptan Succinate Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
